Published in Eur J Pharmacol on July 02, 1997
Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc Natl Acad Sci U S A (1999) 1.88
Nicotinamide protects against ethanol-induced apoptotic neurodegeneration in the developing mouse brain. PLoS Med (2006) 1.32
Role of nicotinamide in DNA damage, mutagenesis, and DNA repair. J Nucleic Acids (2010) 0.96
Nicotinamide reduces hypoxic ischemic brain injury in the newborn rat. Brain Res Bull (2005) 0.90
Variable toxicological response to the loss of OXPHOS through 1-methyl-4-phenylpyridinium-induced mitochondrial damage and anoxia in diverse neural immortal cell lines. Cell Biol Toxicol (2010) 0.81
Nicotinamide inhibits alkylating agent-induced apoptotic neurodegeneration in the developing rat brain. PLoS One (2011) 0.81
The biochemical pathways of central nervous system neural degeneration in niacin deficiency. Neural Regen Res (2014) 0.81
The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease. Int J Mol Sci (2011) 0.80
A systematic proteomic study of irradiated DNA repair deficient Nbn-mice. PLoS One (2009) 0.78
Nutraceuticals in Parkinson's Disease. Neuromolecular Med (2016) 0.76
Neuroprotective profile of pyruvate against ethanol-induced neurodegeneration in developing mice brain. Neurol Sci (2013) 0.76
Nicotinamide adenine dinucleotide suppresses epileptogenesis at an early stage. Sci Rep (2017) 0.75
High-performance liquid chromatography analysis of oxidized and reduced pyridine dinucleotides in specific brain regions. Anal Biochem (1995) 1.87
Plasma glutathione and glutathione disulfide in the rat: regulation and response to oxidative stress. J Pharmacol Exp Ther (1983) 1.79
Reported cigarette smoke values: a closer look. Am J Public Health (1983) 1.75
Increased stress response and beta-phenylethylamine in MAOB-deficient mice. Nat Genet (1997) 1.69
Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Res (1986) 1.45
Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103. J Clin Oncol (1993) 1.44
Improving tapping mode atomic force microscopy with piezoelectric cantilevers. Ultramicroscopy (2004) 1.39
The delivery and uptake of nicotine from an aerosol rod. Am J Public Health (1986) 1.39
Formation and analysis of carbon monoxide in cigarette mainstream and sidestream smoke. Prev Med (1979) 1.27
Studies on the biotransformation of ketamine. 1-Identification of metabolites produced in vitro from rat liver microsomal preparations. Biomed Mass Spectrom (1981) 1.26
Hepatic glutathione homeostasis in the rat: efflux accounts for glutathione turnover. Hepatology (1984) 1.23
Acrolein-induced oxygen radical formation. Free Radic Biol Med (1993) 1.22
Toxic and carcinogenic agents in dry and moist snuff. J Natl Cancer Inst (1987) 1.16
Tobacco sidestream smoke: uptake by nonsmokers. Prev Med (1984) 1.15
Carcinogenic tobacco-specific N-nitrosamines in snuff and in the saliva of snuff dippers. Cancer Res (1981) 1.11
CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians in Los Angeles. Pharmacogenetics (1998) 1.07
Carcinogenic agents in cigarette smoke and the influence of nitrate on their formation. Carcinogenesis (1984) 1.07
On the formation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone during smoking. Cancer Lett (1983) 1.05
Biotransformation of ketamine, (Z)-6-hydroxyketamine, and (E)-6-hydroxyketamine by rat, rabbit, and human liver microsomal preparations. Xenobiotica (1987) 1.04
Reaction of nicotine and sodium nitrite: formation of nitrosamines and fragmentation of the pyrrolidine ring. J Org Chem (1978) 1.04
Cadmium and nickel in smoke of cigarettes prepared from tobacco cultured on municipal sludge-amended soil. J Toxicol Environ Health (1982) 1.02
Assessment of tobacco-specific N-nitrosamines in tobacco products. Cancer Res (1979) 0.99
Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E. Mol Chem Neuropathol (1991) 0.94
Toxicity studies on clove cigarette smoke and constituents of clove: determination of the LD50 of eugenol by intratracheal instillation in rats and hamsters. Arch Toxicol (1986) 0.93
Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate. Am J Med (1990) 0.93
Toxic and carcinogenic agents in undiluted mainstream smoke and sidestream smoke of different types of cigarettes. Carcinogenesis (1987) 0.92
Medicinal chemistry of nicotinamide in the treatment of ischemia and reperfusion. Mini Rev Med Chem (2002) 0.91
Cadmium and nickel in mainstream particulates of cigarettes containing tobacco grown on a low-cadmium soil-sludge mixture. J Toxicol Environ Health (1985) 0.91
Redox cycling of MPP+: evidence for a new mechanism involving hydride transfer with xanthine oxidase, aldehyde dehydrogenase, and lipoamide dehydrogenase. Free Radic Biol Med (1993) 0.88
Myocardial metabolism during exposure to carbon monoxide in the conscious dog. J Appl Physiol (1973) 0.88
Nicotinamide as a precursor for NAD+ prevents apoptosis in the mouse brain induced by tertiary-butylhydroperoxide. Neurosci Lett (1996) 0.87
Explosives: a microsensor for trinitrotoluene vapour. Nature (2003) 0.86
Oxidative changes in brain pyridine nucleotides and neuroprotection using nicotinamide. Biochim Biophys Acta (2001) 0.86
Carcinogenic agents in snuff. J Natl Cancer Inst (1986) 0.86
The effects of oxidative stress on in vivo brain GSH turnover in young and mature mice. Mol Chem Neuropathol (1997) 0.85
Uptake of sidestream smoke by Syrian golden hamsters. Toxicol Lett (1987) 0.85
On the pharmacokinetics of tobacco-specific N-nitrosamines in Fischer rats. Carcinogenesis (1985) 0.85
Brain oxidative stress--analytical chemistry and thermodynamics of glutathione and NADPH. Curr Top Med Chem (2001) 0.84
1-Methyl-4-phenylpyridine (MPP+) induces oxidative stress in the rodent. Life Sci (1986) 0.83
Induction of respiratory tract tumors in Syrian golden hamsters by a single dose of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and the effect of smoke inhalation. Carcinogenesis (1983) 0.82
Apoptosis and oxidative stress in the aging brain. Ann N Y Acad Sci (1996) 0.82
Pharmacokinetics of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in laboratory animals. Cancer Lett (1985) 0.81
Hydration status affects mood state and pain sensation during ultra-endurance cycling. J Sports Sci (2015) 0.80
MPP+ and MPDP+ induced oxygen radical formation with mitochondrial enzymes. Free Radic Biol Med (1993) 0.80
Effects of MPTP on the cerebrovasculature. Int J Dev Neurosci (1991) 0.80
New aspects of brain oxidative stress induced by tert-butylhydroperoxide. Free Radic Biol Med (1993) 0.80
Inhibition of 3-methylindole bioactivation by the cytochrome P-450 suicide substrates 1-aminobenzotriazole and alpha-methylbenzylaminobenzotriazole. Drug Metab Dispos (1989) 0.79
Hematologic responses to hypobaric hyperoxia. Am J Physiol (1972) 0.79
Chemical studies on tobacco smoke LXVIII. Analysis of volatile and tobacco-specific nitrosamines in tobacco products. IARC Sci Publ (1980) 0.79
The effects of aging and neurodegeneration on apoptosis-associated DNA fragmentation and the benefits of nicotinamide. Mol Chem Neuropathol (1998) 0.79
Implant-associated infections: an overview. J Long Term Eff Med Implants (2006) 0.78
Effects of medium conditioned by retinal pigmented epithelial cells on neurotransmitter phenotype in retinoblastoma cells. Cancer Lett (1993) 0.78
Tobacco specific N-nitrosamines: occurrence and bioassays. IARC Sci Publ (1982) 0.78
The neuropathology of intracerebroventricular t-butylhydroperoxide. Mol Chem Neuropathol (1994) 0.78
Relative potency estimates of acceptable residues and reentry intervals after nerve agent release. Ecotoxicol Environ Saf (1992) 0.78
Pharmacokinetics of tobacco-specific N-nitrosamines. IARC Sci Publ (1984) 0.78
Operative cholangiography--its value in the unsuspected choledochal stone. Surg Clin North Am (1972) 0.78
Decreased pneumotoxicity of deuterated 3-methylindole: bioactivation requires methyl C-H bond breakage. Toxicol Appl Pharmacol (1987) 0.78
MPP+ redox cycling: a new mechanism involving hydride transfer. Ann N Y Acad Sci (1992) 0.78
Hydration Status over 24-H Is Not Affected by Ingested Beverage Composition. J Am Coll Nutr (2015) 0.78
MPTP toxicity in the mouse brain and vitamin E. Neurosci Lett (1990) 0.77
Drug interaction in psoriasis. Australas J Dermatol (1976) 0.77
Metabolism of phencyclidine. The role of iminium ion formation in covalent binding to rabbit microsomal protein. Drug Metab Dispos (1983) 0.77
Optimal performance health. Making sure employees run on all cylinders without rustout or burnout. Adm Radiol (1989) 0.77
Plasma glutathione disulfide as an index of oxidant stress in vivo: effects of carbon tetrachloride, dimethylnitrosamine, nitrofurantoin, metronidazole, doxorubicin and diquat. Res Commun Chem Pathol Pharmacol (1984) 0.77
Response. Eur J Appl Physiol (2015) 0.77
Perianal hidradenitis suppurativa. Surg Clin North Am (1972) 0.77
Pneumocystis carinii pneumonia in HIV infected patients: effects of the diseases on glutathione and glutathione disulfide. J Med (1993) 0.76
Effectiveness of cigarette filter tips for reducing cadmium in relation to other mainstream smoke constituents. Drug Chem Toxicol (1987) 0.76
Quantification of glutathione and glutathione disulfide in human plasma. Clin Chem (1987) 0.76
A study of snuff carcinogenesis. IARC Sci Publ (1987) 0.76
Effect of snuff and nicotine on DNA methylation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis (1987) 0.76
Age-dependent effects of t-BuOOH on glutathione disulfide reductase, glutathione peroxidase, and malondialdehyde in the brain. Mol Chem Neuropathol (1995) 0.76
Apoptosis and DNA fragmentation as induced by tertiary butylhydroperoxide in the brain. Brain Res Bull (1995) 0.76
A critical look at N-nitrosamines in environmental tobacco smoke. Toxicol Lett (1987) 0.76
Perturbations in cerebral oxygen radical formation and membrane order following vitamin E deficiency. Biochem Biophys Res Commun (1989) 0.76
Ambulatory use of high-dose intravenous morphine for severe pain. Drug Intell Clin Pharm (1984) 0.76
Tyrosine hydroxylase: mechanisms of oxygen radical formation. Redox Rep (1998) 0.76
N-nitrosamines in laboratory animal feed and bedding. Lab Anim Sci (1983) 0.76
Chemical studies on tobacco-specific N-nitrosamines in the smoke of selected cigarettes from the U.S.A., West Germany, and France. J Anal Toxicol (1981) 0.76
Free radical induction in the brain and liver by products of toluene catabolism. Biochem Pharmacol (1993) 0.76
Transfer of the tobacco-specific carcinogens N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene into the milk of lactating rats. Carcinogenesis (1987) 0.76
Recent developments on the role of mitochondria in poly(ADP-ribose) polymerase inhibition. Curr Med Chem (2003) 0.75
Zoonoses. N Z Med J (1998) 0.75
Acne resistance to antibiotics. N Z Med J (1995) 0.75
II.2.d Tobacco-specific nitrosamines in tobacco and tobacco smoke. IARC Sci Publ (1983) 0.75
Systemic sensitization to ethanol by transdermal estrogen patches. Arch Dermatol (1993) 0.75
IV.6 HPLC-TEA of tobacco-specific nitrosamines. IARC Sci Publ (1983) 0.75
Health and stress management education in three federal agencies. J Health Hum Resour Adm (1983) 0.75
Reader troubled by "refreshing view". Pa Med (1992) 0.75
Carl Paxson Sherwin, American pioneer in drug metabolism. Drug Metab Rev (1992) 0.75